This variant is therefore expected to perturb signaling downstream of PKD1, a kinase with roles in the development and metastatic progression of several cancers including prostate, breast, gastrointestinal, pancreatic, and skin cancers (Sundram et al., 2011). This evidence concerns the gene PKD1 and skin neoplasm.